Next Level Indiana Trust Fund Announces Administrator

Posted: Updated:
INDIANAPOLIS -

A Chicago-based firm has been selected to be administrator of the $250 million Next Level Indiana Trust Fund. The fund's investment board says 50 South Capital Advisors LLC, which has an office in Indianapolis, will work toward developing a portfolio of 20-30 diversified funds through a fund-of-funds approach. The Next Level Indiana Trust Fund was launched last year and was a pillar of Governor Eric Holcomb's inaugural legislative agenda.

The fund has receiving praise from the state's technology community. Indiana has long trailed other states in venture capital funding and financial support for early-stage companies that often present higher risks for investors. The Next Level fund is designed to help close that gap and its board's policy "emphasizes good investment performance, growing Indiana's investment community, and developing technology businesses in Indiana. Investments may be made in venture capital, private credit, private equity and growth."

In an interview last year with TechPoint Chief Executive Officer Mike Langellier, he said the creation of the fund demonstrated that Indiana is "going from laggard to leader" in venture capital.

The fund, established by the Indiana Finance Authority, is a charitable trust operating separately from the state and its board serves as its trustee. 50 South Capital Advisors targets small and middle-market investments, which the state says aligns it well with the mission of the Next Level Indiana Trust Fund.

  • Perspectives

    • Time Management: When and How to Work to Your Max Productivity

      Time is the one resource in your life that is neither replenishable nor renewable. Regardless of how you spin it, everyone starts each day on an equal playing field with 24 hours in the time bank. And while people often yearn for more time, what they really need is better time management. Understanding where your time goes, when you are most productive, and why you should protect yourself against distractions are the keys to achieving your max productivity.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Photo courtesy of MutualBank

      MutualBank President Dies

      The President and Chief Operating Officer of Muncie-based MutalBank Pat Botts has died. In a statement on Facebook posted Sunday, the company said the passing was unexpected.

    • Artist rendering of proposed headquarters for Ruoff Home Mortgage in Fort Wayne.

      Ruoff to Build New HQ in Downtown Fort Wayne

      Fort Wayne-based Ruoff Home Mortgage has announced plans to build a $43 million corporate headquarters in downtown Fort Wayne. Plans call for a 110-thousand square foot, nine-story structure, at the corner of Ewing Street and Jefferson Boulevard. The building would include leasable office and retail space, as well as a parking garage. It would overlook Parkview Field, home of the Fort Wayne Tin Caps minor league baseball team. The company is currently located on...

    • Photo courtesy of Indiana Premium outlets

      Simon Announces New Name for Shopping Center

      Indianapolis-based Simon Property Group Inc. (NYSE: SPG) has announced Edinburgh Premium Outlets will become Indiana Premium Outlets. The company says extensive enhancements are currently underway to reflect the new name and are slated for completion by Holiday 2019. 

    • (stock image courtesy of Pixabay/Gerd Altmann)

      Hoosier Banks Rated for Work Environment

      Three Indiana banks have been judged as Best Banks to Work for in the U.S. by American Banker. The publication compiled a list of the top 85 banks in the country having a good work environment and strong, engaging leadership. 

    • FDA Approves Lilly Migraine Drug

      The U.S. Food and Drug Administration has given another approval for a drug from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The approval of REYVOW is for the treatment of patients with acute migraines.